Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Autolus Therapeutics plc

NASDAQ: AUTL · Life Sciences · 2 alerts · CIK 1730463

Share price
$1.14Close, Nov 16
Market cap
$304M
Shares outstanding
266.34MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Autolus Therapeutics plc filings on SEC EDGAR ↗

4:48 PM ET 10-Q
Financial Results

Autolus Therapeutics Q3 2026 Results: Net Loss of $55.1M, Loss Narrows

Autolus Therapeutics plc, a foreign private issuer voluntarily filing a Form 10-Q, reported 266,340,330 ordinary shares outstanding as of November 9, 2026. The filing highlights the commercialization of AUCATZYL for adult r/r B-ALL and notes a restructuring and workforce reduction plan initiated in April 2026.

Key figure
Net loss $55.1M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.